Navigation Links
Many More Patients Can Now Benefit from Avastin's Proven Survival Benefits
Date:1/27/2008

Avastin Receives Broad Label Extension in Europe for the Treatment of

Patients with Metastatic Colorectal Cancer

BASEL, Switzerland, Jan. 28 /PRNewswire/ -- Roche announced today that the European Commission (EC) has given its approval for the significantly wider use of its anti-angiogenic agent Avastin(bevacizumab) in patients suffering from metastatic colorectal cancer.

This new broader label will now allow Avastin to be used in combination with any chemotherapy, including Roche's oral chemotherapy Xeloda (capecitabine)*, for 1st and later treatment lines in patients with metastatic colorectal cancer. This news means that virtually all patients with metastatic colorectal cancer now have access to Avastin's proven survival benefits. It is estimated that more than 400,000 people in Europe will be diagnosed with colorectal cancer in 2008.(1)

The Avastin approval follows the European Committee for Medicinal Products for Human Use (CHMP) positive recommendations for the extended use of both Avastin and Xeloda in December 2007. *The final EC decision on Xeloda for its extended use is expected imminently.

The new Avastin label will allow it to be used in combination with every standard fluoropyrimidine based chemotherapy and also allows for combinations with Xeloda or oxaliplatin. Avastin formerly could only be used in combination with IV 5-FU or IV 5-FU/irinotecan-based chemotherapy regimen (2) where it had demonstrated an impressive survival extension of nearly 5 months. Physicians now have the flexibility to use Avastin with a broad variety of standard chemotherapy of their choice in any line of metastatic colorectal cancer.

"This is a major turning point in the treatment of metastatic colorectal cancer patients," said Professor Alberto Sobrero, Head of Medical Oncology, Hospital San Martino, Genoa, Italy. "This approval means that many more patients can benefit from Avastin's significant survival benefits."
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... June 19, 2013 Amerinet, Inc, ... ARAMARK Healthcare Technologies to help Pacific Medical Centers ... savings of more than 17 percent over the ... expenditures. , “Driving economies of scale and process ... management challenges facing multi-site providers,” said Shawn Padilla, ...
(Date:6/19/2013)... New data, published today in Menopause International ... experiencing less sex, and less satisfying sex compared ... they are considerably less likely to access appropriate ... atrophy1. , The first-of-its-kind study, called the CLarifying ... study, showed that British post-menopausal women with vaginal ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... MA (PRWEB) June 19, 2013 ... , a premier kids entertainment media organization, and ... serious games company, will be introducing the Games ... StudenTopia. The 3D game is geared toward students ... eating and active lifestyles by rewarding positive choices. ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5
... DaVita Inc., a,leading provider of kidney care services ... kidney failure, is honored to receive the eHealthcare,Leadership ... the,Consumer/Disease-Focused category. DaVita.com was one of 1,100 entries,submitted ... program,recognizes websites in the healthcare industry such as ...
... BRIDGEWATER, N.J., Dec. 8 R&J Public Relations, a ... retained to engage in public relations initiatives to promote ... MAQUET is a leading global provider of medical ... technologies. , , ...
... Water is a critical ingredient in the manufacturing process ... quality water (HQW) is the single biggest driver for ... in the pharmaceutical sector. Frost & Sullivan,s European Environment ... wastewater management market in the European pharmaceutical industry has ...
... Cleveland Clinic,s Department of Orthopaedic Surgery, available for download as a PDF, ... ... (PRWEB) December 8, 2008 -- In 2008, 240,000 people in the United ... not inevitable. A new guide from Cleveland Clinic includes a multitude ...
... has joined the staff at the St. John-Clark Pain ... St. John, Randall Clark, Tracy Alan Jones, Brunella Lucchi ... rest of the clinic,s dream team. From chicago, ... recruiting top therapists from across the country who specialize ...
... , ... West Chester, PA (PRWEB) December 5, 2008-- ... of its Precious Metal tubing production capacity due to increasing demand ... metals - Platinum, in particular - are characterized by a high ...
Cached Medicine News:Health News:DaVita.com Receives eHealthcare Leadership Award 2Health News:R&J Public Relations Selected to Promote MAQUET Inc.'s VARIOP Operating Room Suite in North America 2Health News:Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 3Health News:The St. John-Clark Pain Treatment Center Forms Manual Therapy 'Dream Team' 2Health News:Johnson Matthey Medical Announces Expansion 2
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently ... need to urgently address this issue has been emphasized by ... , "Medical device alarm safety in hospitals." According to The ... June 2012, there were 98 alarm related events reported, of ... , 13 resulted in permanent loss of function (13%) ...
(Date:6/19/2013)... Calif. , June 19, 2013  Finesse ... solutions for life sciences process applications, announced the ... bioreactors for upstream cell culture and fermentation.  The ... new product family of Finesse bioreactors and are ... cGMP applications.  They are fully compatible with all ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... June 18 Watson Pharmaceuticals, Inc. (NYSE: ... Watson management will provide an overview and update of the ... on Wednesday, June 23, 2010 at 11:15am ... . The presentation will be webcast live and can be ...
... , RESEARCH TRIANGLE PARK, N.C. , June 18 ... of Talecris Biotherapeutics (Nasdaq: TLCR ), received the Ernst ... health sciences category in the Carolinas at a ceremony last ... awards program recognizes entrepreneurs who demonstrate extraordinary success in the ...
Cached Medicine Technology:Watson to Present at the Wells Fargo Securities 2010 Healthcare Conference 2Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients 2
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: